Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing <i>Enterobacteriaceae</i> in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR)
BMJ open